Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Rady Children's Institute for Genomic Medicine, |
RCV000853356 | SCV000996232 | likely pathogenic | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2018-12-31 | criteria provided, single submitter | clinical testing | This variant has been previously reported as in patients with molybdenum cofactor deficiency (PMID: 9921896). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.006% (14/245472) and thus is presumed to be rare. The c.377G>A (p.Gly126Asp) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.377G>A (p.Gly126Asp) variant is classified as likely pathogenic. |
Labcorp Genetics |
RCV000853356 | SCV002173523 | likely pathogenic | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2023-12-10 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 126 of the MOCS1 protein (p.Gly126Asp). This variant is present in population databases (rs372246702, gnomAD 0.01%). This missense change has been observed in individuals with molybdenum cofactor deficiency (PMID: 921896, 32014857; Invitae). ClinVar contains an entry for this variant (Variation ID: 692063). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Ce |
RCV001528779 | SCV004032673 | likely pathogenic | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | MOCS1: PM3:Strong, PM2, PP3 |
Baylor Genetics | RCV000853356 | SCV004193247 | likely pathogenic | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001528779 | SCV001741116 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528779 | SCV001957592 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |